Literature DB >> 29302819

Completing the Dissection in Melanoma: Increasing Decision Precision.

Mark B Faries1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29302819      PMCID： PMC6047764          DOI： 10.1245/s10434-017-6330-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  19 in total

1.  Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study.

Authors:  F H Sim; W F Taylor; D J Pritchard; E H Soule
Journal:  Mayo Clin Proc       Date:  1986-09       Impact factor: 7.616

2.  Evidence for a better nodal staging system for melanoma: the clinical relevance of metastatic disease confined to the sentinel lymph nodes.

Authors:  Michael Reintgen; Lauren Murray; Kurt Akman; Rosemary Giuliano; Alyson Lozicki; Steve Shivers; Douglas Reintgen
Journal:  Ann Surg Oncol       Date:  2012-10-05       Impact factor: 5.344

Review 3.  Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis.

Authors:  Tracey DiSipio; Sheree Rye; Beth Newman; Sandi Hayes
Journal:  Lancet Oncol       Date:  2013-03-27       Impact factor: 41.316

4.  Technical details of intraoperative lymphatic mapping for early stage melanoma.

Authors:  D L Morton; D R Wen; J H Wong; J S Economou; L A Cagle; F K Storm; L J Foshag; A J Cochran
Journal:  Arch Surg       Date:  1992-04

5.  Staging of regional lymph nodes in melanoma: a case for including nonsentinel lymph node positivity in the American Joint Committee on Cancer staging system.

Authors:  Anna M Leung; Donald L Morton; Junko Ozao-Choy; Danielle M Hari; Myung Shin-Sim; Andrew L Difronzo; Mark B Faries
Journal:  JAMA Surg       Date:  2013-09       Impact factor: 14.766

6.  Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme.

Authors:  N Cascinelli; A Morabito; M Santinami; R M MacKie; F Belli
Journal:  Lancet       Date:  1998-03-14       Impact factor: 79.321

7.  Non-Sentinel Node Risk Score (N-SNORE): a scoring system for accurately stratifying risk of non-sentinel node positivity in patients with cutaneous melanoma with positive sentinel lymph nodes.

Authors:  Rajmohan Murali; Chitra Desilva; John F Thompson; Richard A Scolyer
Journal:  J Clin Oncol       Date:  2010-09-07       Impact factor: 44.544

8.  Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

Authors:  Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Omgo E Nieweg; Daniel F Roses; Harold J Hoekstra; Constantine P Karakousis; Christopher A Puleo; Brendon J Coventry; Mohammed Kashani-Sabet; B Mark Smithers; Eberhard Paul; William G Kraybill; J Gregory McKinnon; He-Jing Wang; Robert Elashoff; Mark B Faries
Journal:  N Engl J Med       Date:  2014-02-13       Impact factor: 91.245

9.  Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011.

Authors:  John A Olson; Linda M McCall; Peter Beitsch; Pat W Whitworth; Douglas S Reintgen; Peter W Blumencranz; A Marilyn Leitch; Sukamal Saha; Kelly K Hunt; Armando E Giuliano
Journal:  J Clin Oncol       Date:  2008-07-20       Impact factor: 44.544

10.  Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients.

Authors:  K P Wevers; R Murali; E Bastiaannet; R A Scolyer; A J Suurmeijer; J F Thompson; H J Hoekstra
Journal:  Eur J Surg Oncol       Date:  2012-11-06       Impact factor: 4.424
View more
  2 in total

Review 1.  Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials.

Authors:  Mark B Faries; Dale Han; Michael Reintgen; Lauren Kerivan; Douglas Reintgen; Corrado Caracò
Journal:  Clin Exp Metastasis       Date:  2018-05-18       Impact factor: 5.150

2.  The neutrophil-lymphocyte ratio and locoregional melanoma: a multicentre cohort study.

Authors:  Alyss V Robinson; Claire Keeble; Michelle C I Lo; Owen Thornton; Howard Peach; Marc D S Moncrieff; Donald J Dewar; Ryckie G Wade
Journal:  Cancer Immunol Immunother       Date:  2020-01-23       Impact factor: 6.968
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.